The Biotechnology Blog
Biotechnology News
Subscribe to RSS FeedWockhardt gets USFDA nod for marketing Augmentin (Business Standard India)
Pharmaceutical and biotechnology major Wockhardt received USFDA approval for marketing and oral suspension of a combination of Amoxycillin and Clavulanate Potassium.
Wockhardt gets USFDA nod for marketing Augmentin (Business Standard India)
Pharmaceutical and biotechnology major Wockhardt received USFDA approval for marketing and oral suspension of a combination of Amoxycillin and Clavulanate Potassium.
Wockhardt gets USFDA nod for marketing Augmentin (Business Standard India)
Pharmaceutical and biotechnology major Wockhardt received USFDA approval for marketing and oral suspension of a combination of Amoxycillin and Clavulanate Potassium.
Biotechnology leaders call for government support (Times Online)
British biotech has become the latest industry to plead for a government bailout as a result of the credit crisis.
Biotechnology leaders call for government support (Times Online)
British biotech has become the latest industry to plead for a government bailout as a result of the credit crisis.
Biotechnology leaders call for government support (Times Online)
British biotech has become the latest industry to plead for a government bailout as a result of the credit crisis.
Final Glance: Biotechnology companies (INO News)
Amgen fell $1.13 or 2.0 percent, to $56.34. Biogen Idec fell $.42 or 1.0 percent, to $41.70.
Final Glance: Biotechnology companies (INO News)
Amgen fell $1.13 or 2.0 percent, to $56.34. Biogen Idec fell $.42 or 1.0 percent, to $41.70.
Final Glance: Biotechnology companies (INO News)
Amgen fell $1.13 or 2.0 percent, to $56.34. Biogen Idec fell $.42 or 1.0 percent, to $41.70.
Midday Glance: Biotechnology companies (INO News)
Amgen fell $.49 or .8 percent, to $56.98. Biogen Idec fell $.20 or .5 percent, to $41.92.